Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions, except share and per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
4,788 |
|
|
|
646 |
|
|
|
89 |
|
|
|
|
2,843 |
|
|
|
5,191 |
|
|
|
711 |
|
|
|
|
53,088 |
|
|
|
35,639 |
|
|
|
4,883 |
|
Investments in subsidiaries and consolidated VIEs |
|
|
188,817 |
|
|
|
230,090 |
|
|
|
31,522 |
|
Prepayments and other assets |
|
|
154 |
|
|
|
65 |
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249,690 |
|
|
|
271,631 |
|
|
|
37,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,536 |
|
|
|
24,898 |
|
|
|
3,411 |
|
|
|
|
7,083 |
|
|
|
7,188 |
|
|
|
985 |
|
Accrued expenses and other liabilities |
|
|
213 |
|
|
|
198 |
|
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,832 |
|
|
|
32,284 |
|
|
|
4,424 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares (US$0.00002 par value; 100,000,000,000 shares authorized; 2,860,222,213 Class A ordinary shares issued and 2,820,978,543 outstanding, 323,212,124 Class B ordinary shares issued and 316,685,372 outstanding as of December 31, 2023; 2,865,069,999 Class A ordinary shares issued and 2,587,296,615 outstanding, 322,483,772 Class B ordinary shares issued and 316,136,640 outstanding as of December 31, 2024.) |
|
|
— |
* |
|
|
— |
* |
|
|
— |
* |
Additional paid-in capital |
|
|
184,204 |
|
|
|
182,404 |
|
|
|
24,989 |
|
|
|
|
6,109 |
|
|
|
6,688 |
|
|
|
916 |
|
|
|
|
(3,409 |
) |
|
|
(27,739 |
) |
|
|
(3,800 |
) |
|
|
|
44,051 |
|
|
|
76,573 |
|
|
|
10,491 |
|
Accumulated other comprehensive income |
|
|
903 |
|
|
|
1,421 |
|
|
|
195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders’ equity |
|
|
231,858 |
|
|
|
239,347 |
|
|
|
32,791 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders’ equity |
|
|
249,690 |
|
|
|
271,631 |
|
|
|
37,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Absolute value is less than RMB1 million or US$1 million. |
|
Condensed Statements of Operations and Comprehensive Income |
Condensed Statements of Operations and Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
|
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2 |
) |
|
|
(4 |
) |
|
|
(5 |
) |
|
|
(1 |
) |
General and administrative |
|
|
(331 |
) |
|
|
(204 |
) |
|
|
(155 |
) |
|
|
(21 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(333 |
) |
|
|
(208 |
) |
|
|
(149 |
) |
|
|
(20 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from subsidiaries and consolidated VIEs |
|
|
10,667 |
|
|
|
24,967 |
|
|
|
41,991 |
|
|
|
5,753 |
|
Other income/(expense), net |
|
|
48 |
|
|
|
(591 |
) |
|
|
(483 |
) |
|
|
(67 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,382 |
|
|
|
24,168 |
|
|
|
41,359 |
|
|
|
5,666 |
|
|
|
|
(2 |
) |
|
|
(1 |
) |
|
|
— |
* |
|
|
— |
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,380 |
|
|
|
24,167 |
|
|
|
41,359 |
|
|
|
5,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
5,131 |
|
|
|
1,862 |
|
|
|
518 |
|
|
|
71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
15,511 |
|
|
|
26,029 |
|
|
|
41,877 |
|
|
|
5,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Absolute value is less than RMB1 million or US$1 million. |
|
Condensed Statements of Cash Flows |
Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
|
Net cash used in operating activities |
|
|
(509 |
) |
|
|
(765 |
) |
|
|
(717 |
) |
|
|
(98 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of time deposits and wealth management |
|
|
— |
|
|
|
(2,833 |
) |
|
|
(4,979 |
) |
|
|
(682 |
) |
Maturity of time deposits and wealth management |
|
|
1 |
|
|
|
— |
|
|
|
2,838 |
|
|
|
389 |
|
Cash received from internal companies |
|
|
7,426 |
|
|
|
12,633 |
|
|
|
18,773 |
|
|
|
2,572 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
7,427 |
|
|
|
9,800 |
|
|
|
16,632 |
|
|
|
2,279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repurchase of ordinary shares |
|
|
(1,823 |
) |
|
|
(2,497 |
) |
|
|
(25,912 |
) |
|
|
(3,550 |
) |
|
|
|
(13,087 |
) |
|
|
(6,741 |
) |
|
|
(8,263 |
) |
|
|
(1,132 |
) |
|
|
|
10,563 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
(7,005 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Proceeds from unsecured senior notes, net of issuance costs |
|
|
— |
|
|
|
— |
|
|
|
13,999 |
|
|
|
1,918 |
|
Other financing activities |
|
|
1,043 |
|
|
|
33 |
|
|
|
27 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(10,309 |
) |
|
|
(9,205 |
) |
|
|
(20,149 |
) |
|
|
(2,760 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
1,003 |
|
|
|
(71 |
) |
|
|
92 |
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
|
(2,388 |
) |
|
|
(241 |
) |
|
|
(4,142 |
) |
|
|
(567 |
) |
Cash and cash equivalents at beginning of year |
|
|
7,417 |
|
|
|
5,029 |
|
|
|
4,788 |
|
|
|
656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year |
|
|
5,029 |
|
|
|
4,788 |
|
|
|
646 |
|
|
|
89 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|